Cannabix and AlcoPro Enter MOU for Marijuana Breathalyzer Marketing
UF startup Cannabix Technologies announced it has entered into an MOU with AlcoPro to collaborate on marketing efforts for the Cannabix Marijuana Breathalyzer in the U.S.
Three UF Faculty Members Honored With Presidential Early Career Award for Scientists and Engineers
Three UF researchers have received the Presidential Early Career Award for Scientists and Engineers (PECASE), one of the highest honors awarded to scientists by the U.S. government.
UF College of Medicine Launches Pediatric Obesity Fellowship To Tackle National Epidemic
UF's Pediatric Obesity Fellowship Training Program is paving the way for specialized training to address the growing need for obesity prevention and treatment.
UF Study of Deadly Dog Cancer Reveals New Clues for Improved Treatment
UF researchers have identified a crucial link between a gene mutation and immune system signaling in canine hemangiosarcoma, a discovery that could lead to better treatments for both dogs and humans with similar cancers.
AI in Florida Agriculture Will Improve Farming, Create Careers and Put Better Food on Your Table
The University of Florida is pioneering new artificial intelligence programs to help Florida farmers become more productive, leveraging cutting-edge technology to provide more nutritious and affordable food."
UF Researchers Leverage AI To Predict Factors Influencing Lung Disease
UF researchers may leverage AI to uncover measurements that predict the initial tipping point of lung function decline in chronic obstructive pulmonary disease.
Humanities Play Integral Role in the UF Astraeus Space Institute
UF Astraeus Space Institute combines imagination, science, and humanities to advance interdisciplinary research in space exploration, fostering collaboration among engineers, scientists, and humanists
National Science Foundation Awards University of Florida $300K To Reduce Phosphorus in South Florida Ecosystems
UF researchers have secured a $300,000 NSF grant to reduce phosphorus levels in freshwater ecosystems such as the Everglades.
Rise Therapeutics Receives FDA IND Clearance To Initiate Clinical Testing of R-5780 in Cancer
UF startup Rise Therapeutics announced that the U.S. FDA has accepted its investigational new drug (IND) application to proceed with a cancer Phase 1 clinical trial for its program candidate, R-5780.
Research Snapshot: Researchers Identify Genes That Predict Pediatric AML Outcomes
UF researchers identified genes that were associated with resistance or sensitivity to chemotherapy and linked these with patients’ treatment outcomes.
